Organon Co Stock Price Down 3.48 percent on Nov 12

OGN Stock  USD 8.72  0.87  9.07%   
About 58% of Organon's investor base is looking to short. The analysis of overall sentiment of trading Organon Co stock suggests that many investors are alarmed at this time. Organon's investing sentiment overview a quick insight into current market opportunities from investing in Organon Co. Many technical investors use Organon stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Shares of Organon Co fell 3.48 percent in mid-day trading on Nov 12. The stock reached an intraday low of 15.25, before recovering slightly to 15.26, dow

Read at gurufocus.com
Gurufocus Stories at Macroaxis
  

Organon Current Investor Sentiment

Comfort Level 42

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Organon's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Organon Co.

Organon Historical Investor Sentiment

Investor biases related to Organon's public news can be used to forecast risks associated with an investment in Organon. The trend in average sentiment can be used to explain how an investor holding Organon can time the market purely based on public headlines and social activities around Organon Co. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Organon's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Organon and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Organon news discussions. The higher the estimate score, the more favorable the investor's outlook on Organon.

Organon Fundamental Analysis

We analyze Organon's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Organon using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Organon based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Revenue

Revenue Comparative Analysis

Organon is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Organon Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Organon stock to make a market-neutral strategy. Peer analysis of Organon could also be used in its relative valuation, which is a method of valuing Organon by comparing valuation metrics with similar companies.

Peers

Organon Related Equities

LLYEli Lilly   0.26   
16.0%
AMGNAmgen   0.41   
26.0%
MRKMerck   0.41   
26.0%
AZNAstraZeneca PLC   0.48   
31.0%
JNJJohnson Johnson   0.72   
47.0%
GILDGilead Sciences   0.84   
54.0%
BMYBristol Myers   1.01   
66.0%
NVSNovartis   1.06   
69.0%
ABBVAbbVie   1.21   
79.0%
PFEPfizer   1.36   
88.0%
BIIBBiogen   1.40   
91.0%
SNYSanofi ADR   1.53   
100.0%
When determining whether Organon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organon Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organon Co Stock:
Check out Organon Hype Analysis, Organon Correlation and Organon Performance.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.81)
Earnings Share
2.88
Revenue Per Share
24.91
Quarterly Revenue Growth
(0)
Return On Assets
0.0739
The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.